[1]周菁,徐瑜,张明慧,等.瘤内注射慢病毒载体介导的Bmi1-shRNA对A549皮下移植瘤的抑制作用[J].第三军医大学学报,2010,32(20):2177-2180.
 Zhou Jing,Xu Yu,Zhang Minghui,et al.Intratumoral injection of recombinant lentivirus-mediated Bmi1-shRNA inhibits growth of A549 xenografts in mice[J].J Third Mil Med Univ,2010,32(20):2177-2180.
点击复制

瘤内注射慢病毒载体介导的Bmi1-shRNA对A549皮下移植瘤的抑制作用(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
32卷
期数:
2010年第20期
页码:
2177-2180
栏目:
论著
出版日期:
2010-10-30

文章信息/Info

Title:
Intratumoral injection of recombinant lentivirus-mediated Bmi1-shRNA inhibits growth of A549 xenografts in mice
作者:
周菁徐瑜张明慧胡义德
第三军医大学新桥医院全军肿瘤诊治研究所
Author(s):
Zhou Jing Xu Yu Zhang Minghui Hu Yide
Cancer Research Center, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China
关键词:
非小细胞肺癌肿瘤生长抑制慢病毒载体Bmi1
Keywords:
non-small cell lung cancer tumor growth-inhibition   Bmi1
分类号:
R73-362;R734.2;R373
文献标志码:
A
摘要:
目的   探讨瘤内注射慢病毒介导的原癌基因Bmi1的特异性短发夹RNA(Bmi1-shRNA)对人非小细胞肺癌免疫缺陷鼠皮下种植瘤生长的抑制作用。   方法   建立NOD/SCID(非肥胖糖尿病/重症联合免疫缺陷)小鼠人肺癌A549荷瘤模型,共27只,分为3组。其中治疗组移植瘤内注射含有Bmi1-shRNA的慢病毒载体,阴性对照组注射含有NC-shRNA 的慢病毒载体,空白对照注射同剂量PBS。通过激光共聚焦观察移植瘤内绿色荧光蛋白(GFP)表达,RT-PCR、Western blot检测Bmi1 mRNA、蛋白水平的表达,观察RNA干扰效果,测量肿瘤体积,计算肿瘤抑制率。   结果   将A549细胞移植到NOD/SCID鼠背部皮下,成瘤率为100%。激光共聚焦观察治疗组及阴性对照组皮下移植肿瘤组织中有GFP表达,而空白对照组未见GFP表达。治疗组NOD/SCID小鼠的肿瘤体积较阴性对照组和空白对照组显著缩小(P<0.05),肿瘤抑制率分别为52.9%和57.9%。Bmi1-shRNA治疗组中的Bmi1蛋白明显降低,相对空白对照组和阴性对照组,蛋白表达抑制率分别为51.1%、50.3%,差异有显著性(P<0.05)。   结论   利用慢病毒载体成功将Bmi1-shRNA导入移植瘤细胞内,检测到Bmi1蛋白表达的下调,且Bmi1的下调能显著抑制A549小鼠移植瘤的生长。
Abstract:
Objective  To investigate the inhibitory effect of lentivirus-mediated Bmi1-shRNA on transplanted human non-small cell lung cancer (NSCLC) by intratumoral injection.    Methods  Recombinant lentivirus containing Bmi1-shRNA was constructed. A model of subcutaneous implanted tumor was generated through injecting human lung cancer cell A549 (107) into the NOD/SCID mice. The 27 established mice with a mass at a diameter of 4 to 5 mm were divided into 3 groups randomly and equally. Recombinant lentivirus containing Bmi1-shRNA (5×108 TU/ml, 0.1 ml), lentivirus containing NC-shRNA (5×108 TU/ml, 0.1 ml, as negative controls) and PBS (0.1 ml, as blank control) was given the mice of the 3 groups respectively, once per 3 d, for 4 weeks. The size of the tumor mass were measured every 3 d. The mice were sacrificed in the end of 4 weeks’ treatment. The expression of GFP in the xenografts was detected through laser scanning confocal microscope. RT-PCR and Western blot analysis were used to test the mRNA and protein expressions of Bmi1 in the xenografts.    Results  GFP was expressed in the tumor mass of the recombinant lentivirus groups, but not in the blank control. The average tumor volume in Bmi1-shRNA lentivirus group was significantly lower than that in the negative control and blank control groups (P<0.05) with an inhibitory rate of 52.9 % and 57.9% respectively. RT-PCR and Western blotting showed that the mRNA and protein expression of Bmi1 was decreased in the Bmi1-shRNA lentivirus group (P<0.05).    Conclusion  Intratumoral injection of recombinant Bmi1-shRNA Lentivirus inhibits the growth and proliferation of A549 xenografts in the NOD/SCID mice, suggesting that Bmi1 might represent a therapeutic target in the genotherapies of non-small cell lung cancer.

参考文献/References:

周菁, 徐瑜, 张明慧, 等. 瘤内注射慢病毒载体介导的Bmi1-shRNA对A549皮下移植瘤的抑制作用[J].第三军医大学学报,2010,32(20):2177-2180.

相似文献/References:

[1]蒋娟,易亭伍,张瑜,等.非小细胞肺癌的肿瘤干细胞与非肿瘤干细胞中表皮生长因子受体基因异质性的研究[J].第三军医大学学报,2012,34(20):2039.
 Jiang Juan,Yi Tingwu,Zhang Yu,et al.Genetic heterogeneity of EGFR in cancer and non-cancer stem cells from non-small cell lung cancer[J].J Third Mil Med Univ,2012,34(20):2039.
[2]杨庆羚,刘翩,王斌,等.EGFR-TKIs治疗晚期非小细胞肺癌并发间质性肺炎4例报告并文献复习[J].第三军医大学学报,2012,34(20):2060.
 Yang Qingling,Liu Pian,Wang Bin,et al.Interstitial pneumonia in EGFR-TKIs-treated non-small-cell lung cancer: report of 4 cases and review of the literature[J].J Third Mil Med Univ,2012,34(20):2060.
[3]斯晓燕,张力.西妥昔单抗联合化疗一线治疗非小细胞肺癌20例临床观察[J].第三军医大学学报,2012,34(20):2063.
 Si Xiaoyan,Zhang Li.Outcomes of cetuximab combined with chemotherapy as first line therapy in 20 patients with non-small cell lung cancer[J].J Third Mil Med Univ,2012,34(20):2063.
[4]罗虎,罗丹,宫亮,等.联合CIK细胞与化疗对比单纯化疗治疗中晚期非小细胞肺癌的Meta分析[J].第三军医大学学报,2012,34(20):2119.
[5]张瑞萍,吴继华,黄英武,等.循环肿瘤细胞检测指导老年非小细胞肺癌个体化治疗1例[J].第三军医大学学报,2012,34(22):2248.
[6]闫霞,曹官铭,王导新.吉西他滨联合卡铂治疗老年非小细胞肺癌的临床评价[J].第三军医大学学报,2007,29(19):1913.
 YAN Xia,CAO Guan-min,WANG Dao-xin.Gemcitabine plus carboplatin regimen in treatment of advanced non-small cell lung cancer in aged patients[J].J Third Mil Med Univ,2007,29(20):1913.
[7]闵发胜,陈正堂.人非小细胞肺癌与外周血淋巴细胞表达LRP的相关性研究[J].第三军医大学学报,2007,29(17):1699.
 MIN Fa-sheng,CHEN Zheng-tang.Correlation between expression of lung resistance-related protein in non-small cell lung cancer and that in peripheral blood lymphocytes[J].J Third Mil Med Univ,2007,29(20):1699.
[8]高娟,饶进军,吴少瑜,等.丁酸钠与顺铂联用对非小细胞性肺癌细胞生长的抑制作用[J].第三军医大学学报,2007,29(11):1066.
 GAO Juan,RAO Jin-jun,WU Shao-yu,et al.Combination of sodium butyrate and cisplatin has antiproliferative effects on non-small lung cancer cell line[J].J Third Mil Med Univ,2007,29(20):1066.
[9]郑顺利,杨庆生,马小红.非小细胞肺癌患者纵隔淋巴结和外周血中MUC1基因的检测及意义[J].第三军医大学学报,2006,28(24):2472.
[10]张云嵩,范士志,王东,等.APE1在非小细胞肺癌中的表达特点及其与预后的关系[J].第三军医大学学报,2007,29(09):776.
 ZHANG Yun-song,FAN Shi-zhi,WANG Dong,et al.APE1 expression and its correlation with prognosis in non-small cell lung cancer[J].J Third Mil Med Univ,2007,29(20):776.

更新日期/Last Update: 2010-10-19